PA

Pravisha Arya

Active Director Director DIN 10614855
DIN 10614855 First appointment May 2024 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2024
Shareholding value •••• Premium profile

About Pravisha Arya

Data last updated:

Pravisha Arya is a Director at Xenex Pharmaceuticals Private Limited (since 2024). The company operates in Pharma. Xenex Pharmaceuticals Private Limited reported revenue of ₹55.1 Lakh (FY 2024).

DIN 10614855
Primary Designation Director
Industry Pharma
First Appointment 06 May 2024
Oldest Company Age 7 yrs
Largest company Xenex Pharmaceuticals Private Limited · ₹55.1 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director06 May 20242019₹55.1 Lakh (FY 2024)Active

Directorship timeline

Open interactive timeline →
Xenex Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Pravisha Arya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pravisha Arya

Pravisha Arya currently holds 1 directorship: Xenex Pharmaceuticals Private Limited (Director, since 06 May 2024, revenue ₹55.1 Lakh (FY 2024)).

Pravisha Arya was first appointed on 06 May 2024 as Director at Xenex Pharmaceuticals Private Limited.

The current boards of Pravisha Arya's companies include Alok Arya (Xenex Pharmaceuticals Private Limited), Amit Arya (Xenex Pharmaceuticals Private Limited), Ashok Arya (Xenex Pharmaceuticals Private Limited), Vatsal Arya (Xenex Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available